146 related articles for article (PubMed ID: 27771172)
1. Resveratrol improves treatment outcome and laboratory parameters in patients with Takayasu arteritis: A randomized double-blind and placebo-controlled trial.
Shi G; Hua M; Xu Q; Ren T
Immunobiology; 2017 Feb; 222(2):164-168. PubMed ID: 27771172
[TBL] [Abstract][Full Text] [Related]
2. Curcumin improves treatment outcome of Takayasu arteritis patients by reducing TNF-α: a randomized placebo-controlled double-blind clinical trial.
Shao N; Jia H; Li Y; Li J
Immunol Res; 2017 Aug; 65(4):969-974. PubMed ID: 28349250
[TBL] [Abstract][Full Text] [Related]
3. Effects of resistance exercise on treatment outcome and laboratory parameters of Takayasu arteritis with magnetic resonance imaging diagnosis: A randomized parallel controlled clinical trial.
Li G; Liu F; Wang Y; Zhao M; Song Y; Zhang L
Clin Cardiol; 2020 Nov; 43(11):1273-1278. PubMed ID: 32761844
[TBL] [Abstract][Full Text] [Related]
4. Profiles of serum cytokine levels in Takayasu arteritis patients: Potential utility as biomarkers for monitoring disease activity.
Tamura N; Maejima Y; Tezuka D; Takamura C; Yoshikawa S; Ashikaga T; Hirao K; Isobe M
J Cardiol; 2017 Sep; 70(3):278-285. PubMed ID: 27989502
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of Biological-Targeted Treatments in Takayasu Arteritis: Multicenter, Retrospective Study of 49 Patients.
Mekinian A; Comarmond C; Resche-Rigon M; Mirault T; Kahn JE; Lambert M; Sibilia J; Néel A; Cohen P; Hie M; Berthier S; Marie I; Lavigne C; Anne Vandenhende M; Muller G; Amoura Z; Devilliers H; Abad S; Hamidou M; Guillevin L; Dhote R; Godeau B; Messas E; Cacoub P; Fain O; Saadoun D;
Circulation; 2015 Nov; 132(18):1693-700. PubMed ID: 26354797
[TBL] [Abstract][Full Text] [Related]
6. Systemic pentraxin-3 levels reflect vascular enhancement and progression in Takayasu arteritis.
Tombetti E; Di Chio MC; Sartorelli S; Papa M; Salerno A; Bottazzi B; Bozzolo EP; Greco M; Rovere-Querini P; Baldissera E; Del Maschio A; Mantovani A; De Cobelli F; Sabbadini MG; Manfredi AA
Arthritis Res Ther; 2014 Nov; 16(6):479. PubMed ID: 25394473
[TBL] [Abstract][Full Text] [Related]
7. Anti-tumor necrosis factor therapy in patients with difficult to treat Takayasu arteritis.
Hoffman GS; Merkel PA; Brasington RD; Lenschow DJ; Liang P
Arthritis Rheum; 2004 Jul; 50(7):2296-304. PubMed ID: 15248230
[TBL] [Abstract][Full Text] [Related]
8. The efficacy of mycophenolate mofetil in treating Takayasu arteritis: a systematic review and meta-analysis.
Dai D; Wang Y; Jin H; Mao Y; Sun H
Rheumatol Int; 2017 Jul; 37(7):1083-1088. PubMed ID: 28364217
[TBL] [Abstract][Full Text] [Related]
9. Serial analysis of clinical and imaging indices reveals prolonged efficacy of TNF-α and IL-6 receptor targeted therapies in refractory Takayasu arteritis.
Youngstein T; Peters JE; Hamdulay SS; Mewar D; Price-Forbes A; Lloyd M; Jeffery R; Kinderlerer AR; Mason JC
Clin Exp Rheumatol; 2014; 32(3 Suppl 82):S11-8. PubMed ID: 24093733
[TBL] [Abstract][Full Text] [Related]
10. Short-term effect of leflunomide in patients with Takayasu arteritis: an observational study.
de Souza AW; da Silva MD; Machado LS; Oliveira AC; Pinheiro FA; Sato EI
Scand J Rheumatol; 2012 May; 41(3):227-30. PubMed ID: 22400913
[TBL] [Abstract][Full Text] [Related]
11. Anti TNF-α in refractory Takayasu's arteritis: cases series and review of the literature.
Comarmond C; Plaisier E; Dahan K; Mirault T; Emmerich J; Amoura Z; Cacoub P; Saadoun D
Autoimmun Rev; 2012 Jul; 11(9):678-84. PubMed ID: 22155781
[TBL] [Abstract][Full Text] [Related]
12. Tumor necrosis factor-alpha -308G/A gene polymorphism and novel biomarker profiles in patients with Takayasu arteritis.
Sarkar PG; Gupta MD; Girish MP; Bansal A; Kohli S; Saijpaul R; Tyagi S; Pasha Q
Indian Heart J; 2018 Dec; 70 Suppl 3(Suppl 3):S167-S172. PubMed ID: 30595251
[TBL] [Abstract][Full Text] [Related]
13. Takayasu's arteritis occurring under TNF-α blockers: a new paradoxical effect?
Souabni L; Ben Abdelghani K; Jradi S; Zakraoui L
BMJ Case Rep; 2014 Nov; 2014():. PubMed ID: 25422327
[TBL] [Abstract][Full Text] [Related]
14. Takayasu Arteritis and Spondyloarthritis: Coincidence or Association? A Study of 14 Cases.
Rivière E; Arnaud L; Ebbo M; Allanore Y; Claudepierre P; Dernis E; Ziza JM; Miceli-Richard C; Philippe P; Richez C; Soubrier M; Belkhir R; Seror R; Mariette X; Pavy S;
J Rheumatol; 2017 Jul; 44(7):1011-1017. PubMed ID: 28412700
[TBL] [Abstract][Full Text] [Related]
15. The role of mean platelet volume in patients with Takayasu arteritis.
Peng YF; Guo J; Deng YB
Ann Clin Biochem; 2017 Mar; 54(2):273-278. PubMed ID: 27329216
[TBL] [Abstract][Full Text] [Related]
16. Mycophenolate mofetil reduces disease activity and steroid dosage in Takayasu arteritis.
Shinjo SK; Pereira RM; Tizziani VA; Radu AS; Levy-Neto M
Clin Rheumatol; 2007 Nov; 26(11):1871-5. PubMed ID: 17332971
[TBL] [Abstract][Full Text] [Related]
17. Value of contrast-enhanced ultrasonography of the carotid artery for evaluating disease activity in Takayasu arteritis.
Ma LY; Li CL; Ma LL; Cui XM; Dai XM; Sun Y; Chen HY; Huang BJ; Jiang LD
Arthritis Res Ther; 2019 Jan; 21(1):24. PubMed ID: 30651132
[TBL] [Abstract][Full Text] [Related]
18. Pentraxin-3 as a marker of disease activity in Takayasu arteritis.
Dagna L; Salvo F; Tiraboschi M; Bozzolo EP; Franchini S; Doglioni C; Manfredi AA; Baldissera E; Sabbadini MG
Ann Intern Med; 2011 Oct; 155(7):425-33. PubMed ID: 21969341
[TBL] [Abstract][Full Text] [Related]
19. Tumor necrosis factor inhibitors in patients with Takayasu arteritis: experience from a referral center with long-term followup.
Schmidt J; Kermani TA; Bacani AK; Crowson CS; Matteson EL; Warrington KJ
Arthritis Care Res (Hoboken); 2012 Jul; 64(7):1079-83. PubMed ID: 22328491
[TBL] [Abstract][Full Text] [Related]
20. Development and initial validation of the Indian Takayasu Clinical Activity Score (ITAS2010).
Misra R; Danda D; Rajappa SM; Ghosh A; Gupta R; Mahendranath KM; Jeyaseelan L; Lawrence A; Bacon PA;
Rheumatology (Oxford); 2013 Oct; 52(10):1795-801. PubMed ID: 23594468
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
